| 1 |
28356009 | ECPIRM, a Potential Therapeutic Agent for Cutaneous T-Cell Lymphoma, Inhibits Cell Proliferation and Promotes Apoptosis via a JAK/STAT Pathway. | 2018 |
1 |
| 2 |
28370539 | RARα/RXR synergism potentiates retinoid responsiveness in cutaneous T-cell lymphoma cell lines. | 2017 Nov |
1 |
| 3 |
28412739 | Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma. | 2017 Apr 18 |
1 |
| 4 |
26332008 | Woringer-Kolopp (Pagetoid Reticulosis) disease successful response to bexarotene gel. | 2016 Jan-Feb |
1 |
| 5 |
26742957 | Tazarotene 0.1% Cream as Monotherapy for Early-Stage Cutaneous T-Cell Lymphoma. | 2016 May |
1 |
| 6 |
25592781 | Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma. | 2015 Oct |
1 |
| 7 |
25826424 | Retinoids Bias Integrin Expression and Function in Cutaneous T-Cell Lymphoma. | 2015 Aug |
4 |
| 8 |
22917895 | Acitretin for the treatment of cutaneous T-cell lymphoma. | 2013 Feb |
1 |
| 9 |
23557425 | Role of bexarotene in the treatment of cutaneous T-cell lymphoma: the clinical and immunological sides. | 2013 Apr |
1 |
| 10 |
24278042 | Oral retinoids and rexinoids in cutaneous T-cell lymphomas. | 2013 Feb |
2 |
| 11 |
19845753 | About the cutaneous targets of bexarotene in CTCL patients. | 2010 Aug |
1 |
| 12 |
19845755 | Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene. | 2010 Aug |
1 |
| 13 |
21188096 | Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma. | 2010 Feb 5 |
1 |
| 14 |
25386240 | Acitretin systemic and retinoic acid 0.1% cream supression of basal cell carcinoma. | 2010 Jan 18 |
1 |
| 15 |
19222457 | Bexarotene therapy for mycosis fungoides and Sézary syndrome. | 2009 Jun |
1 |
| 16 |
17474355 | Choices in the treatment of cutaneous T-cell lymphoma. | 2007 Feb |
1 |
| 17 |
17474358 | Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies. | 2007 Feb |
1 |
| 18 |
16516669 | Therapeutic advances in cutaneous T-cell lymphoma (CTCL): from retinoids to rexinoids. | 2006 Feb |
1 |
| 19 |
16882161 | Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion. | 2006 Aug |
1 |
| 20 |
17014481 | Treatment of cutaneous T-cell lymphoma with retinoids. | 2006 Sep-Oct |
2 |
| 21 |
14988678 | Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms. | 2004 Mar |
2 |
| 22 |
14686975 | Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma. | 2003 |
1 |
| 23 |
14710892 | Topical and systemic retinoid therapy for cutaneous T-cell lymphoma. | 2003 Dec |
2 |
| 24 |
12847736 | Treatment of mycosis fungoides with oral bexarotene combined with PUVA. | 2002 Sep |
1 |
| 25 |
11331325 | Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. | 2001 May 1 |
1 |
| 26 |
11707863 | Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL). | 2000 Nov |
3 |
| 27 |
10334392 | Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cells. | 1999 Apr |
1 |
| 28 |
10417530 | Follicular mycosis fungoides. | 1999 Jul |
1 |
| 29 |
10559573 | Cutaneous T cell lymphoma: update of treatment. | 1999 |
1 |
| 30 |
9157537 | [Current therapy concepts in cutaneous T-cell lymphomas]. | 1997 Feb 22 |
1 |
| 31 |
8045054 | Therapeutic approaches in cutaneous lymphoma. | 1994 Apr |
1 |
| 32 |
8475670 | Roferon-A in combination with Tigason in cutaneous T-cell lymphomas. | 1993 |
1 |